These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 25767608)
1. Tailoring Pelvic Lymphadenectomy for Patients with Stage IA2, IB1, and IIA1 Uterine Cervical Cancer. Zhou J; Ran J; He ZY; Quan S; Chen QH; Wu SG; Sun JY J Cancer; 2015; 6(4):377-81. PubMed ID: 25767608 [TBL] [Abstract][Full Text] [Related]
2. Can pelvic lymphadenectomy be omitted in patients with stage IA2, IB1, and IIA1 squamous cell cervical cancer? Wang Y; Yao T; Yu J; Li J; Chen Q; Lin Z Springerplus; 2016; 5(1):1262. PubMed ID: 27536545 [TBL] [Abstract][Full Text] [Related]
3. Can pelvic lymphadenectomy be omitted in stage IA2 to IIB uterine cervical cancer? Togami S; Kamio M; Yanazume S; Yoshinaga M; Douchi T Int J Gynecol Cancer; 2014 Jul; 24(6):1072-6. PubMed ID: 24905616 [TBL] [Abstract][Full Text] [Related]
4. Chemotherapy versus chemoradiotherapy for FIGO stages IB1 and IIA1 cervical squamous cancer patients with lymphovascular space invasion: a retrospective study. Zhang H; Yu R; Zhang L; Wang R; Xiao L BMC Cancer; 2022 Feb; 22(1):202. PubMed ID: 35193525 [TBL] [Abstract][Full Text] [Related]
5. The potential for less radical surgery in women with stage IA2-IB1 cervical cancer. Bai H; Yuan F; Wang H; Chen J; Cui Q; Shen K Int J Gynaecol Obstet; 2015 Sep; 130(3):235-40. PubMed ID: 26070225 [TBL] [Abstract][Full Text] [Related]
7. Can laparoscopic radical hysterectomy be a standard surgical modality in stage IA2-IIA cervical cancer? Hong JH; Choi JS; Lee JH; Eom JM; Ko JH; Bae JW; Park SH Gynecol Oncol; 2012 Oct; 127(1):102-6. PubMed ID: 22683586 [TBL] [Abstract][Full Text] [Related]
8. Predicting Factors for Pelvic Lymph Node Metastasis in Patients with Apparently Early-Stage Endometrial Cancer. Gumtorntip P; Poomtavorn Y; Tanprasertkul C Asian Pac J Cancer Prev; 2022 Feb; 23(2):617-622. PubMed ID: 35225474 [TBL] [Abstract][Full Text] [Related]
9. CPE overexpression is correlated with pelvic lymph node metastasis and poor prognosis in patients with early-stage cervical cancer. Shen HW; Tan JF; Shang JH; Hou MZ; Liu J; He L; Yao SZ; He SY Arch Gynecol Obstet; 2016 Aug; 294(2):333-42. PubMed ID: 26695643 [TBL] [Abstract][Full Text] [Related]
10. Chemotherapy versus radiotherapy for FIGO stages IB1 and IIA1 cervical carcinoma patients with postoperative isolated deep stromal invasion: a retrospective study. Li L; Song X; Liu R; Li N; Zhang Y; Cheng Y; Chao H; Wang L BMC Cancer; 2016 Jul; 16():403. PubMed ID: 27387204 [TBL] [Abstract][Full Text] [Related]
11. Risk factors of pelvic lymph node metastasis in cervical adenocarcinoma following radical hysterectomy and pelvic lymphadenectomy. Yanaranop M; Sathapornteera N; Nakrangsee S J Med Assoc Thai; 2014 Nov; 97 Suppl 11():S87-95. PubMed ID: 25509701 [TBL] [Abstract][Full Text] [Related]
12. Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer. Memarzadeh S; Natarajan S; Dandade DP; Ostrzega N; Saber PA; Busuttil A; Lentz SE; Berek JS Obstet Gynecol; 2003 Sep; 102(3):612-9. PubMed ID: 12962952 [TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis of the incidence and predictive factors of parametrial involvement in FIGO IB1 cervical cancer. Yang Q; Zhou Q; He X; Cai J; Sun S; Huang B; Wang Z J Gynecol Obstet Hum Reprod; 2021 Oct; 50(8):102145. PubMed ID: 33848645 [TBL] [Abstract][Full Text] [Related]
14. Incidence of Lymph Node Metastases in Women With Low-Risk Early Cervical Cancer (<2 cm) Without Lymph-Vascular Invasion. Minig L; Fagotti A; Scambia G; Salvo G; Patrono MG; Haidopoulos D; Zapardiel I; Domingo S; Sotiropoulou M; Chisholm G; Ramirez PT Int J Gynecol Cancer; 2018 May; 28(4):788-793. PubMed ID: 29538254 [TBL] [Abstract][Full Text] [Related]
15. Prognostic factors of 2018 FIGO stage IB-IIA cervical cancer with absence of high/ intermediate surgical-pathological risk factors. Shibuya Y; Shimada M; Tsuji K; Shigeta S; Tanase Y; Matsuo K; Yamaguchi S; Kanao H; Saito T; Mikami M Jpn J Clin Oncol; 2022 Nov; 52(11):1289-1296. PubMed ID: 35913375 [TBL] [Abstract][Full Text] [Related]
16. A machine learning-based prediction model of pelvic lymph node metastasis in women with early-stage cervical cancer. Monthatip K; Boonnag C; Muangmool T; Charoenkwan K J Gynecol Oncol; 2024 Mar; 35(2):e17. PubMed ID: 37921601 [TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease]. Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410 [TBL] [Abstract][Full Text] [Related]
18. Multivariate prognostic analysis of adenocarcinoma of the uterine cervix treated with radical hysterectomy and systematic lymphadenectomy. Kato T; Watari H; Takeda M; Hosaka M; Mitamura T; Kobayashi N; Sudo S; Kaneuchi M; Kudo M; Sakuragi N J Gynecol Oncol; 2013 Jul; 24(3):222-8. PubMed ID: 23875071 [TBL] [Abstract][Full Text] [Related]
19. Extent of lymphovascular space invasion and risk of pelvic lymph node metastases in stage IB1 cervical cancer. Chandacham A; Charoenkwan K; Siriaunkgul S; Srisomboon J; Suprasert P; Phongnarisorn C; Cheewakraingkrai C; Siriaree S; Tantipalakorn C; Kietpeerakool C J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S31-6. PubMed ID: 17722314 [TBL] [Abstract][Full Text] [Related]